Longboard Pharmaceuticals, Lundbeck
M&A News: Lundbeck to Acquire Longboard (NASDAQ:LBPH) for $2.6B
Longboard Pharmaceuticals ($LBPH) soared in trading on Monday after announcing that Dutch pharmaceutical company Lundbeck will acquire the company
Longboard Pharmaceuticals’ stock soars amid Lundbeck’s $2.6 billion deal to acquire the company
H. Lundbeck plans to acquire Longboard Pharmaceuticals in a $2.6 billion deal, the companies announced Monday.
Lundbeck to acquire Longboard Pharmaceuticals in $2.6B deal
Danish pharmaceutical company Lundbeck will buy Longboard Pharmaceuticals (LBPH) in a deal valued at $2.6 billion, with the former hoping to build off of its pipeline of epilepsy drug treatment. Market Domination hosts Julie Hyman and Josh Lipton take a closer look at the details of the deal.
Longboard Pharmaceuticals Strikes $2.6 Billion Deal to Be Acquired by Lundbeck
Longboard Pharmaceuticals (LBPH) on Monday agreed to be acquired by Danish pharmaceutical company H. Lundbeck in a deal with an equity value of about $2.6 billion. Lundbeck will launch a tender offer to purchase all of Longboard's shares for $60 apiece in cash,
Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday?
H. Lundbeck acquires Longboard Pharmaceuticals for $2.6 billion. The acquisition strengthens Lundbeck's pipeline with bexicaserin, a potential treatment for Dravet syndrome and other neurological conditions.
Lundbeck gains bexicaserin with $2.6B Longboard buyout
H. Lundbeck A/S is to acquire Longboard Pharmaceuticals Inc. in an all-cash deal valuing the epilepsy specialist at $2.6 billion. The agreed price of $60 per share is a 54% premium to the closing price of Longboard stock (NASDAQ:LBPH) on Oct.
Denmark's H. Lundbeck To Buy Longboard Pharmaceuticals For $60/share Cash
Danish pharmaceutical company H. Lundbeck A/S (HLUKY.PK, HLUKF.PK) and Longboard Pharmaceuticals, Inc. (LBPH), announced Monday an
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket
Lundbeck agreed to acquire Longboard Pharmaceuticals in a transaction valued at approximately $2.6 billion equity value. Longboard Pharmaceuticals shares jumped 46.8% to $57.13 in the pre-market trading session. Here are some other stocks moving in pre-market trading.
Lundbeck to Buy Longboard Pharmaceuticals in $2.6 Billion Deal
Danish pharmaceutical company H. Lundbeck A/S has agreed to acquire Longboard Pharmaceuticals Inc in a deal with an equity value of $2.6 billion.
Longboard Pharmaceuticals Stock Soars 51%. It’s Being Bought for $2.6 Billion.
Pharmaceutical company Lundbeck will acquire Nasdaq-listed Longboard Pharmaceuticals in a $2.6 billion deal, the two companies said Monday. Denmark-listed H. Lundbeck will make a tender offer for all shares outstanding of Longboard common stock,
Lundbeck to buy neurology-focused Longboard Pharmaceuticals in $2.6 billion deal
The Danish pharma company Lundbeck said Monday it would buy Longboard Pharmaceuticals in a deal worth $2.6 billion
bovnews3h
Acquisition Sparks Surge: The Future of Longboard Pharmaceuticals (LBPH)
Longboard Pharmaceuticals has displayed a staggering YTD performance of +875.79%, significantly outpacing the S&P 500’s +22.85%. This impressive rise highlights not just the company’s operational ...
Joplin Globe10h
LBPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Longboard Pharmaceuticals, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) to H. Lundbeck A/S for $60.00 per share in cash share is fair to ...
Business Insider13h
Longboard Shares Surge In Pre-market On News Of Acquisition
(RTTNews) - Shares of Longboard Pharmaceuticals, Inc. (LBPH) were surging more than 50 percent in pre-market on Monday on the news of it being acquired by H. Lundbeck A/S in a transaction valued ...
The Valdosta Daily Times10h
Shareholder Alert: Ademi LLP Investigates Whether Longboard Pharmaceuticals, Inc. Is Obtaining a Fair Price for Its Public Shareholders
Shareholder Alert: Ademi LLP Investigates Whether Longboard Pharmaceuticals, Inc. Is Obtaining a Fair Price for Its Public Shareholders Ademi LLP is investigating Longboard (NASDAQ: LBPH) for possible ...